|
|
| ^ LLY: Intraday Hourly Forecast Similar Waves GapOpen Research Timing Gains Losses Strategies Practice |
| Mon. Jul. 8, 2019 |
Trading Signals: LLY Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(Eli Lilly and Company)
| LLY latest price $111.5200 (-1.15%) ($110.9100 - $112.7900) on Mon. Jul. 8, 2019. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.37% (three month average) | | RSI | 45 | | Latest Price | $111.5200(-1.15%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | LLY advances 0.1% a day on average for past five trading days. | | Weekly Trend | LLY declines -0.7% a week on average for past two weeks. | | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | | Correlated ETFs | Broad market will support LLY advance at 0% a week (0% probability)
XLV(57%) SPLV(48%) DIA(44%) IBB(44%) SPY(44%) | | Factors Impacting LLY price | LLY will decline at least -0.685% in a week (0% probabilities).
VIXM(-24%) VXX(-12%) TLT(-12%) IFRA(-10%) TIP(-3%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.685% (StdDev 1.37%) | | Hourly BBV | 0 () | | Intraday Trend | -1% | | | | | |
|
| Resistance Level | $113.45 | | 5 Day Moving Average | $113.17(-1.46%) | | 10 Day Moving Average | $113(-1.31%) | | 20 Day Moving Average | $113.45(-1.7%) | | To recent high | -12.4% | | To recent low | 0.7% | | Market Cap | $106.719b | | | | | | |
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through the following segments: Human Pharmaceutical Products and Animal Health Products. The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other. The Animal health Products segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN. | $. LLY price fluctuates within 1.45% (three month std-dev: 1.37%) daily (68% of days).
getNextHourMoveProbability failed |
|